Ingevity (NYSE: NGVT) is one of 31 public companies in the “Commodity Chemicals” industry, but how does it contrast to its competitors? We will compare Ingevity to related companies based on the strength of its analyst recommendations, profitability, valuation, risk, dividends, institutional ownership and earnings.

Analyst Recommendations

This is a breakdown of current ratings for Ingevity and its competitors, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ingevity 0 0 6 0 3.00
Ingevity Competitors 107 820 1224 36 2.54

Ingevity currently has a consensus price target of $76.00, indicating a potential upside of 8.39%. As a group, “Commodity Chemicals” companies have a potential downside of 2.55%. Given Ingevity’s stronger consensus rating and higher possible upside, analysts plainly believe Ingevity is more favorable than its competitors.

Profitability

This table compares Ingevity and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Ingevity 9.86% 58.14% 12.09%
Ingevity Competitors -29.50% 24.34% 5.63%

Risk & Volatility

Ingevity has a beta of 1.78, indicating that its stock price is 78% more volatile than the S&P 500. Comparatively, Ingevity’s competitors have a beta of 1.14, indicating that their average stock price is 14% more volatile than the S&P 500.

Insider and Institutional Ownership

91.4% of Ingevity shares are owned by institutional investors. Comparatively, 70.9% of shares of all “Commodity Chemicals” companies are owned by institutional investors. 0.1% of Ingevity shares are owned by insiders. Comparatively, 7.8% of shares of all “Commodity Chemicals” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Earnings & Valuation

This table compares Ingevity and its competitors top-line revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Ingevity $908.30 million $35.20 million 31.59
Ingevity Competitors $4.01 billion $340.26 million 164.96

Ingevity’s competitors have higher revenue and earnings than Ingevity. Ingevity is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Summary

Ingevity beats its competitors on 8 of the 13 factors compared.

About Ingevity

Ingevity Corporation is a manufacturer of specialty chemicals and high performance carbon materials. The Company is also a manufacturer of activated carbon used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats. The Company operates through two segments: Performance Materials and Performance Chemicals. The Performance Materials segment primarily produces automotive carbon products used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats. The Performance Chemicals segment develops, manufactures and sells a range of specialty chemicals primarily derived from co-products of the Kraft pulping process. Its products are used in a range of applications, including asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, publication inks and automotive components that reduce gasoline vapor emissions.

Receive News & Stock Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related stocks with our FREE daily email newsletter.